SCHEMBL15538264

SCHEMBL15538264

CC(C)(F)CN1CCC(COc2ccc(-c3ccc(C(=O)N4CCCC(O)C4)c(F)c3)nc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 7/20 0.54
ALOX5AP P20292 3/20 0.44
FEN1 P39748 3/20 0.44
PIK3CA P42336 2/20 0.43
MTOR P42345 2/20 0.43
KMT2A Q03164 1/20 0.42
CYP4F2 P78329 3/20 0.39
CYP4A11 Q02928 3/20 0.39
HCRTR1 O43613 1/20 0.39
HCRTR2 O43614 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15538261 1.00 GPR119 (0.54) GPR119ALOX5APFEN1PIK3CAMTOR
SCHEMBL15539460 1.00 GPR119 (0.54) GPR119ALOX5APFEN1PIK3CAMTOR
SCHEMBL15538925 0.95 GPR119 (0.57) GPR119ALOX5APFEN1PIK3CAMTOR
SCHEMBL15537652 0.95 GPR119 (0.57) GPR119ALOX5APFEN1PIK3CAMTOR
SCHEMBL15537654 0.95 GPR119 (0.57) GPR119ALOX5APFEN1PIK3CAMTOR
SCHEMBL15539414 0.93 GPR119 (0.51) GPR119ALOX5APFEN1PIK3CAMTOR
SCHEMBL15539417 0.93 GPR119 (0.51) GPR119ALOX5APFEN1PIK3CAMTOR
SCHEMBL20053576 0.92 GPR119 (0.58) GPR119CYP4F2CYP4A11
SCHEMBL15538474 0.91 PIK3CA (0.44) GPR119ALOX5APFEN1PIK3CAMTOR
SCHEMBL15538147 0.91 PIK3CA (0.44) GPR119ALOX5APFEN1PIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US claimed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP claimed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO claimed
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 GPR119 1/4885ALOX5AP 1652/4885FEN1 4874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.